Literature DB >> 19258180

Complications of echocardiography-guided endomyocardial biopsy.

Kirk P Sloan1, Charles J Bruce, Jae K Oh, Charanjit S Rihal.   

Abstract

A 77-year-old man underwent echocardiography-guided right ventricular endomyocardial biopsy for suspected cardiac amyloidosis. After the procedure, severe tricuspid regurgitation with a flail posterior leaflet was detected. A myocardial biopsy specimen contained a segment of tricuspid valve chorda tendinea. Endomyocardial biopsy is considered the standard for detecting transplant rejection and evaluating infiltrative cardiomyopathies and myocarditis. Echocardiography complements, and in some institutions has replaced, fluoroscopy as a method of bioptome guidance because of its superior resolution of the tricuspid valve anatomy, endocardial surface, and thin right ventricular free wall and apex. Nevertheless, because of the limitations of 2-dimensional imaging, complications do occur.

Entities:  

Mesh:

Year:  2009        PMID: 19258180     DOI: 10.1016/j.echo.2008.12.023

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

Review 1.  Pathophysiology and treatment of cardiac amyloidosis.

Authors:  Morie A Gertz; Angela Dispenzieri; Taimur Sher
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 2.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

3.  Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy.

Authors:  Ayman K M Hassan; Doaa Ahmed Fouad; Abeer Refaiy
Journal:  Egypt Heart J       Date:  2016-10-10

4.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.